Avidity Biosciences
RNA
$24.36
Share price
2.22%
Change (1 day)
67.42%
Change (1 year)
Categories
Avidity Biosciences (RNA) Fails to deliver data
Key failure to deliver metrics for Avidity Biosciences:
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $1.42 M
- Last 3 months FTD volume: $4.54 M
- Last year FTD volume: $5.58 M
Failures to deliver for Avidity Biosciences (RNA) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Avidity Biosciences (RNA) - since 2020
Volume in USD (price x number of shares), data since 2020Avidity Biosciences (RNA) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $4.54 M | 3.47% |
| 2023 | $4.38 M | -91.34% |
| 2022 | $50.7 M | 162.44% |
| 2021 | $19.31 M | -77.68% |
| 2020 | $86.53 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Pfizer PFE | $31.87 M | $0.32 B | 🇺🇸 USA |
 GlaxoSmithKline GSK | $15.53 M | $26.02 M | 🇬🇧 UK |
 Sarepta Therapeutics
SRPT | $6.44 M | $36.3 M | 🇺🇸 USA |
 PTC Therapeutics
PTCT | $2.23 M | $11.86 M | 🇺🇸 USA |
 Fate Therapeutics
FATE | $0.2 M | $1.79 M | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | N/A | $0.02 M | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | $0.42 M | $4.04 M | 🇺🇸 USA |